The Global Tick-borne Encephalitis Inactivated Vaccine Market was valued at USD 327.8 Million in 2023 and is projected to reach USD 512.4 Million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 6.8% during the forecast period (2024–2030). This growth is primarily driven by the increasing incidence of TBE in endemic regions, rising public health awareness, government-led vaccination programs, and a growing emphasis on travel medicine.

As climate change expands the geographical range of tick vectors, the demand for reliable prophylactic measures against this serious neurological disease is accelerating. This blog profiles the Top 10 Companies in the Tick-borne Encephalitis Inactivated Vaccine Industry—a group of pharmaceutical innovators and public health partners dedicated to preventing TBE through advanced immunological solutions.

Download FREE Sample Report:
Tick-borne Encephalitis Inactivated Vaccine Market – View in Detailed Research Report

---

🔟 1. Pfizer Inc.

Headquarters: New York, New York, USA
Key Offering: FSME-IMMUN (licensed in various markets)

Pfizer, a global pharmaceutical leader, markets the highly effective FSME-IMMUN vaccine outside of its primary European markets through strategic licensing agreements. The company leverages its vast distribution network to make the vaccine accessible to travelers and at-risk populations in non-endemic countries.

R&D and Public Health Initiatives:

• Global distribution partnerships for TBE vaccine access

• Investment in public health education on vector-borne diseases

• Commitment to broadening vaccine availability in emerging markets

---

9️⃣ 2. Baxter AG (now part of Pfizer vaccine portfolio)

Headquarters: Vienna, Austria (historical)
Key Offering: FSME-IMMUN (original developer)

Baxter BioScience was the original developer of the FSME-IMMUN vaccine, a cornerstone of TBE prevention. Following Pfizer’s acquisition of Baxter’s vaccine portfolio, the production and innovation legacy continues, ensuring a consistent supply of this critical prophylactic.

Legacy and Impact:

• Pioneering research and development of inactivated TBE vaccines

• Establishment of high safety and efficacy standards for the industry

---

8️⃣ 3. Valneva SE

Headquarters: Saint-Herblain, France
Key Offering: TBE vaccine (marketed in several European countries)

Valneva is a specialty vaccine company focused on providing protection against infectious diseases with limited prevention options. Their TBE vaccine is a key part of their travel and endemic disease portfolio, catering to both local populations and international travelers.

Strategic Focus:

• Specialization in vaccines for diseases with high unmet medical needs

• Expansion of marketing authorizations for their TBE vaccine

---

7️⃣ 4. Pfizer (FSME-IMMUN Manufacturing & Supply)

Headquarters: New York, New York, USA (Global Operations)
Key Offering: FSME-IMMUN bulk manufacturing and global supply

Pfizer’s manufacturing division ensures the robust and reliable global supply of the FSME-IMMUN vaccine. Their state-of-the-art production facilities adhere to stringent quality control standards, guaranteeing the consistency and safety of every batch distributed worldwide.

Supply Chain Leadership:

• World-class GMP manufacturing capabilities

• Complex global logistics for temperature-sensitive biologics

Download FREE Sample Report:
Tick-borne Encephalitis Inactivated Vaccine Market – View in Detailed Research Report

---

6️⃣ 5. LGC Standards (for diagnostic and research components)

Headquarters: Teddington, United Kingdom
Key Offering: Antigens and antibodies for TBE diagnostic assays

While not a vaccine manufacturer, LGC Standards plays a critical supporting role in the TBE ecosystem by providing high-quality reference materials, antigens, and antibodies. These components are essential for diagnostic test development, vaccine efficacy testing, and serological surveillance studies.

Supporting Role:

• Provision of critical materials for vaccine R&D and quality control

• Enabling accurate diagnosis and epidemiological monitoring

---

5️⃣ 6. Encephalitis Global (Awareness and Support Organization)

Headquarters: United Kingdom (International Reach)
Key Offering: Public health advocacy, education, and patient support

Encephalitis Global is a pivotal non-profit organization dedicated to raising awareness about all forms of encephalitis, including TBE. Their work in education and advocacy indirectly supports vaccine markets by increasing public and professional understanding of the disease’s risks and prevention strategies.

Advocacy Initiatives:

• Global awareness campaigns on TBE risks and prevention

• Support for research and improved access to vaccines

---

4️⃣ 7. Supreme Pharma (Potential Distributor in Emerging Markets)

Headquarters: (Regional specific)
Key Offering: Pharmaceutical distribution and cold chain logistics

Regional pharmaceutical distributors, such as those that might operate under names like Supreme Pharma in certain areas, are vital for getting TBE vaccines to clinics and pharmacies in endemic regions. They manage the complex cold chain required to maintain vaccine potency from manufacturer to patient.

Market Access Role:

• Last-mile delivery ensuring vaccine availability in rural and urban centers

• Expertise in maintaining vaccine integrity during storage and transport

---

3️⃣ 8. Cochrane Collaboration (Evidence Synthesis)

Headquarters: London, United Kingdom (Global Network)
Key Offering: Independent, high-quality systematic reviews of medical evidence

The Cochrane Collaboration provides rigorously compiled evidence on vaccine safety and efficacy, which is crucial for informing WHO guidelines and national immunization policies. Their independent analyses help build confidence in TBE vaccines among healthcare providers and the public.

Evidence-Based Impact:

• Systematic reviews supporting TBE vaccine recommendations

• Independent verification of vaccine safety profiles

---

2️⃣ 9. Sonic HealthPlus (Travel Health Provider)

Headquarters: Melbourne, Australia
Key Offering: Travel medicine services, including TBE vaccination

As a major provider of travel health services, Sonic HealthPlus is a key endpoint for vaccine administration. They assess traveler risk, provide pre-travel consultations, and administer TBE vaccines to individuals traveling to endemic areas, directly driving market volume.

Clinical Services:

• Risk assessment and prophylactic vaccination for travelers

• Expert medical advice on TBE and other travel-related diseases

---

1️⃣ 10. Superdrug Health (Retail Health Clinics)

Headquarters: London, United Kingdom
Key Offering: Accessible vaccination services through retail pharmacies

Superdrug Health Clinics in the UK make vaccinations like the TBE vaccine more accessible to the general public. By offering travel health services in a convenient retail setting, they play a significant role in increasing vaccination coverage among travelers.

Consumer Access Initiatives:

• Increasing public access to travel vaccinations

• Integrating preventive health services into retail environments

Get Full Report Here:
Tick-borne Encephalitis Inactivated Vaccine Market – View in Detailed Research Report

---

🌍 Outlook: The Future of TBE Prevention Is Expanding and Evolving

The Tick-borne Encephalitis Inactivated Vaccine market is at a critical juncture, shaped by environmental changes and advancements in vaccine technology. While current vaccines are highly effective, the industry is focusing on broadening protection, improving accessibility, and adapting to a changing epidemiological landscape.

📈 Key Trends Shaping the Market:

• Expansion of TBE endemic areas due to climate change, increasing the at-risk population

• Growing integration of TBE vaccination into national immunization schedules in endemic countries

• Development of next-generation vaccines with longer duration of immunity and simpler dosing schedules

• Increased traveler awareness and prophylactic vaccination driven by the recovery of the tourism industry

Get Full Report Here:
Tick-borne Encephalitis Inactivated Vaccine Market – View in Detailed Research Report

The companies profiled are not only supplying a critical medical product—they are essential partners in the global public health defense against a serious and potentially fatal neurological disease.